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Evaluation of nanoparticle interference with
viability tests
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Pedro Quaresmae, Eulália Pereirae, Eduardo Pásaroc, Blanca Laffonc
and João Paulo Teixeiraa,bABSTRACT: Superparamagnetic iron oxide nanoparticles (ION) have attracted great interest for use in several biomedical fields. In
general, they are considered biocompatible, but little is known of their effects on the human nervous system. Themain objective
of this work was to evaluate the cytotoxicity of two ION (magnetite), coated with silica and oleic acid, previously determining the
possible interference of the IONwith themethodological procedures to assure the reliability of the results obtained. Human neu-
roblastoma SHSY5Y and glioblastoma A172 cells were exposed to different concentrations of ION (5–300 μg ml–1), prepared in
complete and serum-free cell culture medium for three exposure times (3, 6 and 24 h). Cytotoxicity was evaluated by means of
the MTT, neutral red uptake and alamar blue assays. Characterization of the main physical–chemical properties of the ION tested
was also performed. Results demonstrated that both ION could significantly alter absorbance readings. To reduce these interfer-
ences, protocols weremodified by introducing additional washing steps and cell-free systems. Significant decreases in cell viabil-
ity were observed for both cell lines in specific conditions by all assays. In general, oleic acid-coated ION were less cytotoxic than
silica-coated ION; besides, a serum-protective effect was observed for both ION studied and cell lines. These results contribute to
increase the knowledge of the potential harmful effects of ION on the human nervous system. Understanding these effects is
essential to establish satisfactory regulatory policies on the safe use of magnetite nanoparticles in biomedical applications.
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Nanotechnology is currently one of the fastest-growing industries
on the planet, and its development is accompanied by promises of
substantial benefits that will have significant economic and
scientific impacts (Singh et al., 2009). With the rapid expansion of
the nanotechnology industry, there are increasing concerns as to
the potential adverse human health and environmental effects
that the production and subsequent exposure to nanoparticles
might pose (Clift et al., 2011).
Superparamagnetic iron oxide nanoparticles (ION) have
attracted considerable interest due to their excellent magnetic
properties, biocompatibility and biodegradability. Recent ad-
vances improved the magnetic and physicochemical properties
of ION broadening their potential applications (Stephen et al.,
2011). These magnetic nanoparticles are promising contrast
agents for magnetic resonance imaging and are a major class of
nanoscale material currently under extensive development for
improved diagnosis and treatment of a wide range of diseases,
including cancer, cardiovascular disease and neurological disease
(Xie and Jon, 2012). In general, ION are considered biocompatibleJ. Appl. Toxicol. 2016; 36: 361–372 Copyright & 2015 John(Kunzmann et al., 2011). Nevertheless, little is known on the effects
of ION on the human nervous system as few studies were pub-
lished using human neural cell lines and results obtained wereWiley & Sons, Ltd.
61
362
C. Costa et al.not consistent (Chen et al., 2012; Kenzaoui et al., 2012; Valdiglesias
et al., 2015; Xiang et al., 2003).
For a complete risk assessment of nanoparticles, it is
necessary not only to address the level of exposure to these
materials but also to determine their potential hazard
(Landsiedel et al., 2010). In vitro cytotoxicity testing constitutes
the first step in the assessment of possible interactions between
these particles and biological processes. Among the most
commonly used assays to evaluate in vitro cell cytotoxicity due
to nanoparticle exposure one may find 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT), alamar blue (AB)
and neutral red uptake (NRU) assays. These are all colorimetric
assays but differ in principle and therefore offer complementary
information on mechanistic processes of cytotoxicity. The MTT
assay is based on the intracellular reduction of the MTT reagent
to insoluble formazan by NAD(P)H-dependent enzymes
(Berridge et al., 1996). Rezasurin (reagent used in the AB assay)
can be reduced also by cytochromes and other enzymes located
in the cytoplasm changing from indigo blue (oxidized: resazurin)
to a pink species (reduced: resorufin) (Rampersad, 2012). The
NRU assay is based on the ability of viable cells to incorporate
and bind the supravital dye NR in the lysosomes. The uptake
of NR depends on the cell capacity to maintain pH gradients,
through the production of ATP, and therefore the amount of
retained dye is proportional to the number of viable cells. In
addition, the uptake of NR by viable cells can be modified
by alterations in cell surface or lysosomal membranes (Repetto
et al., 2008).
Previous studies on ION cytotoxicity have been conducted in
different cell lines and show conflicting results as some studies
showed no alterations on viability (e.g., Dunning et al. [2004]
found no significant difference in Schwann cell viability using
propidium iodide assay after exposure to dextran-coated ION)
while others indicate cell toxicity (e.g., mesenchymal cells
showed a decrease in viability after exposure to Endorem®
ION by water-soluble tetrazolium salt assay; Babič et al.,
2009). A number of factors could be based on these con-
flicting results. Although differences in the physicochemical
characteristics of these nanoparticles, such as size and surface
modification, seem to be the main reason for these variations
(Hong et al., 2011), inattention to interference of the tested
nanoparticles with the experimental procedures can also be
responsible for false results (either positive or negative)
(Domey et al., 2014). Correct in vitro assessment of nanoparti-
cle cytotoxicity entails a careful choice of the test systems
and it should always include the analysis of possible inter-
ferences with the optical detection methods and reagents,
the ability to convert the substrates and/or the influence on
enzymatic activity. Besides, some authors suggest the use of a
combinatorial approach to cell viability and cytotoxicity screening
by carrying out different assays to monitor nanomaterial cyto-
toxicity to identify the most meaningful and representative
in vitro result (Wörle-Knirsch et al., 2006).
The present study aims to evaluate cytotoxicity of two ION
with different coatings (silica and oleic acid coating) on both
human neuroblastoma (SHSY5Y) and human glioblastoma
(A172) cell lines by using the classical in vitro cytotoxicity assays,
MTT, NRU and AB. An in-depth evaluation of all potential
interferences, including the absorbance range of the
nanoparticles and expected interactions with assay components
was also completed to guarantee the reliability of the results
obtained.Copyright & 2015 Johnwileyonlinelibrary.com/journal/jatMaterials and methods
Chemicals
The MTT (CAS no. 298-93-1), NR dye (CAS no. 553-24-2), rezasurin
(CAS no. 62758-13-8) and Triton X-100 (CAS no. 9002-93-1) were
purchased from Sigma-Aldrich Co. (Sintra, Portugal) Dimethyl sulf-
oxide (DMSO; CAS no. 37-68-5), acetic acid ( glacial) 100% (CAS no.
64-19-7), and ethanol absolute (CAS no. 64-17-5) were bought
from Merck KGaA (Darmstadt, Germany). Cell culture media com-
ponents were all Invitrogen products and purchased from Thermo
Fisher Scientific Inc. (Uppsala, Sweden).
Nanoparticle preparation
Iron oxide nanoparticles coated with silica (S-ION) and oleic acid
(OA-ION) were synthesized and prepared as stable water stock sus-
pensions (S-ION 5 mg ml–1 and OA-ION 19 mg ml–1) as described
by Yi et al. (2006) and Maity and Agrawal (2007), respectively. Be-
fore each treatment, a 1 mg ml–1 suspension was prepared in wa-
ter, complete or incomplete medium and sonicated in water bath
for 5 min. Serial dilutions were carried out to obtain the different
ION concentrations tested and sonicated in the water bath for an
additional 5 min period.
Nanoparticle characterization
Primary particle size and particlemorphologywere characterized by
monolayer transmission electronmicroscopy (TEM) using a HITACHI
H-8100 microscope equipped with EDS (ThermoNoran; Thermo
Scientific, Hitachi, Tokyo, Japan) operated at 200 kV. Images were
analyzed using ImageJ public domain software. The average hydro-
dynamic size and zeta potential of particles in suspension were de-
termined by dynamic light scattering (DLS) and mixed mode
measurement phase analysis light scattering, respectively, using a
Zetasizer Nano-ZS equipped with 4.0 mW, 633 nm laser (Model
ZEN 3600; Malvern Instruments Ltd., Malvern, Worcs, UK).
Photoelectron spectroscopy (XPS) was used to determine parti-
cle surface chemistry. The XPS analysis was performed using a
ESCALAB 200A, VG Scientific (East Grinstead, UK) with PISCES soft-
ware for data acquisition and analysis. For analysis, an achromatic
Al (Kα) X-ray source (1486.6 eV) operating at 15 kV (300 W) was
used, and the spectrometer, calibrated with reference to Ag
3d5/2 (368.27 eV), was operated in CAE mode with a pass energy
of 20 eV (ROI) and 50 eV (survey). Data acquisition was performed
with a pressure lower than 1 × 10–6 Pa. The surface charging effect
was corrected using the carbon peak as reference (285 eV). The
deconvolution of spectra was performed using the XPSPEAK41
program, in which an adjustment of the peaks was performed
using peak fitting with a Gaussian–Lorentzian peak shape and
Shirley type background subtraction.
Cell cultures
Human neuroblastoma SHSY5Y and human glioblastoma A172 cell
lines were obtained from the European Collection of Cell Cultures.
SHSY5Y was cultured in nutrient mixture EMEM/F12 (1:1) medium
with 1% non-essential amino acids, 1% antibiotic and antimycotic
solution, and supplemented with 10% heat-inactivated fetal bo-
vine serum. Culture media of the A172 cell line consisted of
Dulbecco minimal Eagle’s medium (high glucose) with 2 mM of
glutamine, 1% antibiotic and antimycotic solution and 10% fetal
bovine serum.J. Appl. Toxicol. 2016; 36: 361–372Wiley & Sons, Ltd.
Cytotoxicity and interference of IONCells were incubated in a humidified atmosphere with 5% CO2
at 37 °C. To carry out the experiments, 3 × 104 cells were seeded
in 96-well plates (flat bottom) and allowed to adhere for 24 h at
37 °C. For cell treatments, these were incubated at 37 °C for dif-
ferent periods in the presence of the different ION concentrations,
or control solutions.Exposure conditions
For each assay and each nanoparticle, 10 different concentrations
(5, 10, 25, 50, 75, 100, 150, 175, 200 and 300 μgml–1), in addition to
a negative and a positive control, and three exposure periods (3, 6
and 24 h) were evaluated. Culture medium (specific for each cell
line) without ION was used as negative control in all experiments.
Triton X-100 (1%) was used as positive control for all assays.Interference studies
To reveal possible interferences between ION and cytotoxicity as-
says experimental procedure, two sets of experiments were con-
ducted, (1) to analyze the influence of ION presence on
absorbance measurements (light absorption interference), and
(2) to address possible ION reactivity with assay components. Both
sets of experiments were carried out in the absence of cells.
Analysis of influence of iron oxide nanoparticle presence on absor-
bance measurements (light absorption interference). For the MTT
and NRU assays, light absorption interference was analyzed in
the presence of dissolving agents (DMSO and fixative solution,
for the MTT and NRU assay, respectively) and end-products
(formazan dissolved in DMSO and NR dissolved in fixative solu-
tion). End-products were obtained by incubating live cells with
the MTT and NRU dyes (as described below in the assay sections).
ION suspensions were prepared in solvents and end-products at
three concentrations (50, 100 and 300 μg ml–1). Absorbance was
measured at 570 nm and 540 nm, for the MTT and NRU, respec-
tively, using a Cambrex ELx808 microplate reader (KC4; Biotek,
Winooski, VT, USA) and compared to blanks (no ION addition).
For the AB assay, ION suspensions were prepared in both
resazurin and resorufin. Resorufin was obtained after reduction
with formic acid. Since in this assay resazurin reduction occurs in
the presence of cell culture media, experiments were carried out
using incomplete and complete media of the SHSY5Y and A172
cell lines. ION suspensions (50, 100 and 300 μg ml–1) were added
to the same amount of cell culture media and absorbance was im-
mediately measured at 570 nm with a reference wavelength of
630 nm (Cambrex ELx808 microplate reader, KC4; Biotek).
Iron oxide nanoparticle reactivity with assay components. This was
determined by performing the assays in the absence of cells (4 h of
incubation for the MTT and AB, and 3 h for the NRU) (Holder et al.,
2012; Kroll et al., 2011). In brief, ION were incubated with assay re-
agents in the absence of cells and absorbance measured at the
end of the incubation period was compared to blank absorbance
(no ION addition).36MTT assay
The MTT assay was performed according to Mosmann (1983).
Briefly, after exposure, treatment suspensions were removed, wells
were washed with phosphate-buffered saline (PBS) twice, and 100
μl of the MTT dye (500 μg ml–1) dissolved in serum-free medium
were added to each well and the plate was incubated at 37 °CJ. Appl. Toxicol. 2016; 36: 361–372 Copyright & 2015 Johnfor 4 h (protected from light). At the end of this period, the MTT
solution was removed and 200 μl of DMSO were added. For com-
plete dissolution of purple formazan crystals, the content of each
well was quickly resuspended and the plate was kept away from
light for an additional period of 5–10 min. Absorbance was mea-
sured at 570 nm using a Cambrex ELx808 microplate reader
(KC4; Biotek) and values of ION alone (experiments without cells)
were used to correct absorbance obtained in each tested
condition.Neutral red uptake assay
As previously described by Valdiglesias et al. (2013), at the end of
the exposure period ION were removed, wells were washed twice
with PBS, and 100 μl of NR reagent, prepared in incomplete me-
dium (50 μg ml–1), were added to cells and incubated for 3 h at
37 °C. After removing the NR, 200 μl of fixative solution (50%
ethanol, 1% acetic acid and 49% deionized water) were added to
extract the dye from cells. Absorbance was measured at 540 nm
using a Cambrex ELx808 microplate reader (KC4; Biotek) and
values of ION alone (experiments without cells) were used to cor-
rect absorbance obtained in each tested condition.Alamar blue assay
The AB assay was carried out as previously described (Borra et al.,
2009). At the end of the exposure periods, ION were removed,
wells were washed twice with PBS and the AB reagent (resazurin;
100 μl), prepared in incomplete medium (20 μg ml–1), was added
to the cells, and then incubated for 4 h at 37 °C. Spectrophotomet-
ric absorbance was taken at 570 nm with a reference wavelength
of 630 nm, using a Cambrex ELx808 microplate reader (KC4;
Biotek). Absorbance values of ION alone (experiments without
cells) were used to correct absorbance obtained in each tested
condition.Statistical analysis
Statistical analyses were performed using SPSS for Windows statis-
tical package (version 22.0). Non-parametric tests (Mann–Whitney
U-test [differences among groups] and Spearman’s correlation
[associations between two variables]) were used for the statistical
analysis of these data. A minimum of three independent experi-
ments (in viability assays, three replicates were analyzed in each
experiment) were performed for each experimental condition
tested. Experimental data were expressed as mean ± standard
error and a P-value of 0.05 was considered significant.
Results
Nanoparticle characterization
Table 1 summarizes the main physicochemical properties of ION
employed in this study, such as primary size, hydrodynamic size
in water and cell culture media (complete and serum-free), surface
characteristics and electrokinetic potential (indicative of colloidal
stability). TEMmicroscopy revealed, in both cases, a spherical mor-
phology and in the case of S-ION, a core-shell structure with a silica
coating was clearly seen (Fig. 1).
Surface chemistry analysis revealed that only a small fraction of
the ION surface presents iron (less than 7% for OA-ION and 2% for
S-ION). S-ION also presented carbon and nitrogen in their surface,Wiley & Sons, Ltd. wileyonlinelibrary.com/journal/jat
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Figure 1. Transmission electronmicroscopy images and corresponding diameter histograms of the nanoparticles used in this work. (a) Oleic acid-iron oxide
nanoparticles and (b) silica-iron oxide nanoparticles showing both the size of the magnetic core and the total size, including the silica layer.
Cytotoxicity and interference of IONpossibly resultant from the synthesis process (reverse micro-
emulsion using cyclohexane, ammonium hydroxide and tetraethyl
orthosilicate). Hydrodynamic size measurements showed that
ION, both S-ION and OA-ION, maintain their nanoparticle size
when dispersed in water and complete medium but OA-ION
agglomerate notably when dispersed in incomplete medium and
exhibit a size in the micron range (1961.3 nm and 2587.7 nm in
SHSY5Y and A172 incomplete media, respectively). All dispersions
showed a negative charge, but values indicating stable colloidal
dispersions (lower than –30 mV or higher than 30 mV) were only
observed for ION in water.
Nanoparticle interference with in vitro cytotoxicity assays
Absorption spectra of ION studied herein dispersed in water
showed notable absorption levels at wavelengths used in cyto-
toxicity assays, indicating that these nanoparticles may interfere(a)
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Figure 2. Interference of ION with the MTT and NRU assays. Results of inter
*P< 0.05, significantly different from the control. MTT, 3-(4,5-dimethylthiazol-2-y
OA-ION, oleic acid-iron oxide nanoparticles; S-ION, silica-iron oxide nanoparticle
J. Appl. Toxicol. 2016; 36: 361–372 Copyright & 2015 Johnwith the spectrophotometric read-out (data not shown). In this
context, different tests were carried out to assess the possible
interference of ION with the cytotoxicity assays to be used.
As mentioned above, interference with light absorption was
analyzed in the presence of both dissolving agents and reaction
products for the NRU and MTT assays (Fig. 2). Results show that
the presence of ION (both silica- and oleic acid-coated) is re-
sponsible for a significant increase in absorbance in all cases,
with the exception of S-ION, in the presence of solubilized
formazan. In general, it seems that for the NRU and MTT assays,
interference issues are more relevant whenever the assay reac-
tion does not occur (ION dispersed in DMSO or fixative solution),
what means that absorbance is particularly overestimated in
cases of low viability. In addition, interferences were more pro-
nounced for OA-ION.
Regarding the AB assay, interferences were tested in the
presence of SHSY5Y and A172 serum-free cell culture media (since(b)
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C. Costa et al.in this assay, resazurin prepared in incomplete medium is not re-
moved from the wells before colorimetric analysis, as it was done
with the MTT or NR in the previously detailed cytotoxicity assays).
Results obtained are presented in Fig. 3. As evidenced in this
figure, ION were able to interfere significantly with light absor-
bance in both media. For SHSY5Y cell culture media, interferences
were limited to situations of low viability (in which the AB is not re-
duced by cells and, therefore, remains as resazurin at the time of
absorbance measurements). Although the presence of ION nano-
particles significantly altered these readings, the increase observed
was below 20% even for the highest concentration (300 μg ml–1).
Different results were obtained when analyzing ION interference
with the AB assay in the presence of A172 cell culturemedia. In this
case, differences were much more pronounced when readings
were carried out in the presence of resorufin, indicating that inter-
ferences are particularly relevant whenever there is high cell
viability.
The second set of experiments carried out to understand ION in-
terference with cytotoxicity assays intended to analyze the reactiv-
ity of ION with dyes by performing the whole assay protocol with
the ION in the absence of cells. Experiments were performed using
cell culture media of the two cell lines under study but, as results
were found to be similar, only data concerning A172 cell culture
medium are presented (Fig. 4). Results obtained in the presence
of OA-ION showed a significant dose-dependent increase of
formazan production (incomplete medium: r = 0.557, P < 0.001;
complete medium: r = 0.649, P< 0.001) and NRU (incomplete me-
dium: r = 0.654, P< 0.001; complete medium: r = 0.680, P< 0.001).
S-ION were also able to mimic the NRU in incomplete medium
(r = 0.371, P< 0.001). In what concerns the AB assay, no significant
alterations in absorbance were observed (Fig. 3c).Figure 4. Reactivity of ION in the absence of cells with the MTT (a), alamar
blue (b) and NR uptake (c) assay reactants in A172 cell culture medium. NP,
nanoparticle; NR, neutral red; OA-ION, oleic acid-iron oxide nanoparticles;
S-ION, silica-iron oxide nanoparticles.In vitro cytotoxicity
After cell exposure to different concentrations of S-ION and
OA-ION, viability was assessed by employing the MTT, NRU and
AB assays. Results obtained for the SHSY5Y cell line are presented
in Figs. 5 and 6, respectively. Exposure to S-ION in incomplete me-
dium induced a significant decrease in cell viability assessed by the
MTT (3 and 24 h) and NRU assays (6 and 24 h) but not by the AB
assay. In opposition, exposure to S-ION in complete medium was
responsible for a significant decrease in viability only after 24 h
of exposure (more evident in the NRU and AB assays). In what con-
cerns SHSY5Y exposure to OA-ION, there was no clear decrease in
cell viability when exposure was carried out in complete medium.
Nevertheless, in incomplete medium, the highest concentrationsCopyright & 2015 Johnwileyonlinelibrary.com/journal/jatemployed (200 and 300 μg ml–1) reduced the viability of SHSY5Y
cells significantly in the case of the MTT and NRU assays (Fig. 6).
Figures 7 and 8 present A172 viability after exposure to S-ION
and OA-ION, in incomplete and complete media. In accordance
to what was observed in the SHSY5Y cell line, after exposure to
S-ION in incomplete medium, decreases in cell viability of A172
was also observed at all studied times of exposure assessed by
the MTT and NRU assays. Moreover, the decline in viability ob-
served in this cell line was more pronounced than the oneJ. Appl. Toxicol. 2016; 36: 361–372Wiley & Sons, Ltd.
SHSY5Y viability after exposure to S-ION 
Incomplete medium Complete medium
MTT
(a) (b) 
NRU
(c) (d) 
AB
(e) (f)
0
20
40
60
80
100
120
0 5 10 25 50 75 100 150 175 200 300 PC
C
el
l v
ia
bi
lit
y 
(%
)
NP concentration (µg ml-1)
0
20
40
60
80
100
120
0 5 10 25 50 75 100 150 175 200 300 PC
C
el
l v
ia
bi
lit
y 
(%
)
NP concentration (µg ml-1)
0
20
40
60
80
100
120
0 5 10 25 50 75 100 150 175 200 300 PC
C
el
l v
ia
bi
lit
y 
(%
)
NP concentration (µg ml-1)
0
20
40
60
80
100
120
0 5 10 25 50 75 100 150 175 200 300 PC
C
el
l v
ia
bi
lit
y 
(%
)
NP concentration (µg ml-1)
0
20
40
60
80
100
120
0 5 10 25 50 75 100 150 175 200 300 PC
C
el
l v
ia
bi
lit
y(%
)
NP concentration (µg ml-1)
0
20
40
60
80
100
120
0 5 10 25 50 75 100 150 175 200 300 PC
C
el
l v
ia
bi
lit
y 
(%
)
NP concentration (µg ml-1)
Figure 5. Cell viability of the SHSY5Y cell line after exposure to silica-iron oxide NP. Viability was assessed by: MTT assay in incomplete (a) and complete
media (b); neutral red uptake assay in incomplete (c) and completemedia (d); and alamar blue assay in incomplete (e) and completemedia (f ). Bars represent
standard error of the mean. Values were normalized considering negative control as 100%. *P<0.05, significant difference with regard to the corresponding
negative control. NP, nanoparticle; PC, positive control.
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Cytotoxicity and interference of IONobserved in SHSY5Y cells: after 24 h of exposure to 300 μg ml–1 of
S-ION in incomplete medium, A172 cell viability was found to be
lower than 40% in opposition to 58% of SHSY5Y cell viability iden-
tified in the same conditions. Moreover, exposure to S-ION in
incomplete medium for 24 h was also able to decrease cell viability
significantly after analysis by the AB assay (Fig. 7e). In complete
medium, exposure to S-ION was responsible for a reduction in via-
bility after 3 h (MTT assay), 6 h (MTT and NRU assays) and 24 h
(MTT, NRU and AB assays). Percentages of cell viability observed
after exposure to S-ION in complete medium were consistently
higher than those observed after exposure to the same ION in
incomplete medium.
Regarding the effect of OA-ION in A172 viability, it was observed
a significant decrease after 3 h (MTT assay) and 24 h (MTT and AB
assays) of exposure to these ION in incomplete medium. The NRU
results showed significantly decreased levels of live cells only after
exposure to 300 μg ml–1 of OA-ION when compared with the
corresponding control, at all periods of exposure studied. OA-ION
dispersed in complete medium were also responsible for a signifi-
cant reduction in viability after 3 h (MTT and NRU assays), 6 h (NRU
assay) and 24 h (AB assay) of exposure.
Discussion
Throughout the years it has become clear that physicochemical
characterization of test materials is essential in toxicity screening
(Sayes and Warheit, 2009). In addition to primary characterization,
in the current study nanoparticles were also characterized underJ. Appl. Toxicol. 2016; 36: 361–372 Copyright & 2015 Johnbiologically relevant conditions, as these are the most significant
for in vitro nanotoxicology (Warheit, 2008). ION dispersed in cell
culture media showed a larger size and lower stability than those
dispersed in water (both S-ION and OA-ION in either complete or
incomplete media). Previous studies have shown that this increase
in size is due to the formation of agglomerates at physiological pH
and electrolyte concentration (Bihari et al., 2008). Even in water,
these particles present a much larger diameter by DLS than the
one determined by the TEM, indicating that these particles are
not particularly stable. In the case of OA-ION, this can be due to
a partial desorption of the bilayer of oleic acid when the particles
are diluted inwater from the stock solution, while for S-ION it could
be noticed in the TEM images that some particles appear joined to-
gether by the silica layer resulting in amuch greater hydrodynamic
diameter. Results obtained here revealed the importance of serum
presence, particularly for OA-ION. The influence of a dynamic co-
rona has been increasingly studied as it became evident that the
adsorption of proteins present in a biological environment is able
to modify nanomaterial surfaces and their biological impacts
(Lynch and Dawson, 2008). Different studies have shown the im-
portance of serum as a dispersant (leading to improved particle
dispersion and stability over time) and reported that, at the same
time that serum is responsible for size increase due to the forma-
tion of a corona around particles, it also prevents the magnetic
nanoparticles from agglomerating by providing steric hindrance
(Wiogo et al., 2011). DLS results obtained for OA-ION showed that
for these nanoparticles, serum presence is essential to obtain good
particle dispersion, in both SHSY5Y and A172 incomplete media,Wiley & Sons, Ltd. wileyonlinelibrary.com/journal/jat
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Figure 6. Cell viability of the SHSY5Y cell line after exposure to oleic acid-iron oxide NP. Viability was assessed by: MTT assay in incomplete (a) and complete
media (b); neutral red uptake assay in incomplete (c) and completemedia (d); and alamar blue assay in incomplete (e) and completemedia (f ). Bars represent
standard error of the mean. Values were normalized considering negative control as 100%. *P<0.05, significant difference with regard to the corresponding
negative control. NP, nanoparticle; PC, positive control.
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C. Costa et al.OA-ION presented significant agglomeration, as particle average
size was 10 times higher than the one observed in complete
media. On the other hand, S-ION size was not so influenced by
serum presence and presented similar values in both complete
and incomplete media. Coating stability is the probable cause for
these differences between S-ION and OA-ION, as strongly
covalently bound silica shells do not present the possibility of
desorption as oleic acid coating (Wu et al., 2008).
One of the most recently discussed issues of nanotoxicology is
the appropriateness of classical in vitro cytotoxicity assays to assess
cell viability. Different authors have shown that results obtained
may not be reliable due to nanoparticle interference with assay
components (Love et al., 2012; Monteiro-Riviere et al., 2009; Stone
et al., 2009), thus cell death indexes may be either underestimated
(Wörle-Knirsch et al., 2006) or overestimated (Laaksonen et al.,
2007). Possible causes of interference include nanoparticle inter-
ference with light absorption (Kroll et al., 2009), chemical reactions
between nanoparticles and reactants (Monteiro-Riviere et al.,
2009), and dye adsorption on nanoparticle surface (Holder et al.,
2012). Different strategies have been used to obviate interference
between nanoparticles and assay readings: use of cells treated
with the same concentrations of nanoparticles but without assay
reagents as blanks (Hoskins et al., 2012), plate centrifugation be-
fore absorbance measurements (Han et al., 2011), use of cell-free
systems (wells without cells but with all assay reagents) as blanks
(Belyanskaya et al., 2007), or cell wash after incubation period to
remove the remaining nanoparticles (Hoskins et al., 2012). The
evaluation of possible interactions between ION analyzed in thisCopyright & 2015 Johnwileyonlinelibrary.com/journal/jatstudy and cytotoxicity assays showed that interference in results
could not be completely ruled out with these nanoparticles.
S-ION and OA-ION appear to interfere both in optical measure-
ment and assay reaction (by reacting with assay components
and producing measurable end-products). To avoid these interfer-
ences, in the protocols we includedwashing steps after treatments
with the ION and before dye incubation, and a cell-free system to
correct for ION–dye reactivity. Nevertheless, it is difficult to ensure
that all interferences were in fact controlled as some ION are inter-
nalized by cells and probably interfere with optical measurements
(for the MTT and NRU assays, as no reactivity in absence of cells
was detected in the AB assay; Fig. 3c). According to this evidence,
we can conclude that for the MTT the cell viability may be slightly
overestimated, particularly in the case of A172 exposure to S-ION
(case of lowest viability). The results obtained after exposure to
OA-ION can also be overestimated, as in the presence of formazan
these ION are responsible for a significant increase in absorbance.
For the AB assay, the results indicate that viability of the A172 cell
line can be also overestimated. In fact, this possible interference
leading to viability overestimation may explain the increase in via-
bility (above 100%) observed in certain conditions (e.g., in the A172
cell line using the NRU assay in complete medium for 24 h). Never-
theless, previous studies have described increases in cell proliferation
in the presence of nanoparticles. For instance, silver nanoparticles
accelerated proliferation of HepG2 cells at low doses, meanwhile
they exhibited significant cytotoxicity at higher doses (Kawata
et al., 2009), and Ferucarbotran (an ionic superparamagnetic
ION) increased growth of human mesenchymal stem cellsJ. Appl. Toxicol. 2016; 36: 361–372Wiley & Sons, Ltd.
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Figure 7. Cell viability of the A172 cell line after exposure to silica-iron oxide NP. Viability was assessed by: MTT assay in incomplete (a) and completemedia
(b); neutral red uptake assay in incomplete (c) and completemedia (d); and alamar blue assay in incomplete (e) and completemedia (f ). Bars represent stan-
dard error of themean. Values were normalized considering negative control as 100%. *P<0.05, significant difference with regard to the corresponding neg-
ative control. NP, nanoparticle; PC, positive control.
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Cytotoxicity and interference of ION(Huang et al., 2009). In the current study, increases in viability were
only observed in SHSY5Y cells and in a variety of situations, not
restricted to specific times of exposure or concentration ranges.
Nevertheless, cell cycle experiments carried out in the same condi-
tions (same cell lines, cell culture conditions, ION, exposure times
and doses) showed alterations in the regular cell proliferation only
for the highest concentrations and exposure time (data not
shown). Taken together, these results suggest that the increase
in viability may be more likely due to interference of the ION with
the methodologies of the assays than to the actual induction of
cell proliferation.
There are several in vitro studies that have demonstrated little or
no toxicity of ION, which led to the suggestion that these are bio-
compatible nanomaterials (Boyer et al., 2010). Earlier studies on
neurotoxicity of ION revealed a decrease in viability of mouse neu-
roblastoma cells after exposure to bare ION (200 μgml–1), assessed
by the MTT assay ( Jeng and Swanson, 2006). In addition, Au et al.
(2007) and Pisanic-II et al. (2007) described significant decreases in
cell viability of astrocytes and pheochromocytoma neuronal cell
lines, respectively, after exposure to ION. The MTT and AB assays
provide information on mitochondrial activity (Hillegass et al.,
2010), while the NRU assay evaluates lysosomal integrity (Repetto
et al., 2008). More recently, it has been described that a reduction
of the AB can also occur in subcellular components and not only in
mitochondria, which means that AB reduction is related to cellular
metabolism impairment and is not entirely due to interruption of
electron transport and mitochondrial dysfunction (Rampersad,
2012). Previous studies stated that ION are stored in lysosomesJ. Appl. Toxicol. 2016; 36: 361–372 Copyright & 2015 Johnwhere they decompose to free iron (Laskar et al., 2012; Laurent
et al., 2012). Free iron ions can affect mitochondria and/or increase
radical concentration. In addition, ION can also directly damage
mitochondria by causing morphological alterations or decrease
in mitochondrial membrane potential (Frohlich, 2013). Our
results showed the lowest viability detected by the MTT assay,
in comparison with the remaining assays, suggesting that mito-
chondria is particularly sensitive to the ION studied herein in
accordance to what has been stated in previous studies ( Jeng
and Swanson, 2006).
The results obtained suggest that OA-ION present a lower
cytotoxicity than S-ION. The composition of ION coating may be
based on the different cytotoxic effects observed, as it has been
extensively reported that external modification can significantly af-
fect the chemical reactivity of a material and thereby its potential
toxic effects (Hong et al., 2011). On the other hand, one cannot
overlook the differences observed in size when using incomplete
medium. In these conditions, differences observed in toxicity be-
tween the two types of nanoparticles are likely related to disper-
sion, as OA-ION were found to be prone to agglomeration in
serum-free media. As improved dispersion can be responsible for
an increase in particle reactivity (Stone et al., 2009), agglomeration
state and protein corona may actually have implications on the
toxicity of a particle due to alteration of the particle dynamics
and consequent modification of patterns of cell–ION interaction.
An additional factor that must be pointed out is the presence of
carbon and nitrogen on the S-ION surface, which indicates that res-
idues resulting from the synthesis process are still present inWiley & Sons, Ltd. wileyonlinelibrary.com/journal/jat
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Figure 8. Cell viability of the A172 cell line after exposure to oleic acid-iron oxide NP. Viability was assessed by: MTT assay in incomplete (a) and complete
media (b); neutral red uptake assay in incomplete (c) and completemedia (d); and alamar blue assay in incomplete (e) and completemedia (f ). Bars represent
standard error of the mean. Values were normalized considering negative control as 100%. *P<0.05, significant difference with regard to the corresponding
negative control. NP, nanoparticle; PC, positive control.
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C. Costa et al.nanoparticles. If the presence of these residues in nanoparticles
influences toxicity is unknown; however, this is a serial confounder
that must be addressed in further studies (Crist et al., 2013).
The presence of serum in cell culture media is an important fac-
tor to consider as it has been reported that its presence may result
in different biological effects (Geys et al., 2010). Proteins or other
macromolecules present in media immediately bind to nanoparti-
cles creating a protein corona. It has been shown that serum
presence may mask the reactive surface of nanoparticles
preventing a cell–nanoparticle interaction, lower cellular uptake
and neutralize the increased sensitivity of serum-deprived cells
(Frohlich, 2013). Our results confirm this serum-protective effect
as lower viability was observed in incomplete medium, as com-
pared with complete medium, for both ION and cell lines studied.
Two different cell models were used in this study to understand
the potential neurotoxic effects of S-ION and OA-ION. Previous
studies using both neuroblastoma and glioblastoma cell lines to
address metal oxide nanoparticle toxicity have shown that the
SHSY5Y cell line is usuallymore sensitive than the glioblastoma cell
lines (Chen et al., 2008). On the other hand, other studies on
chemical toxicity suggest that glial cellsmay bemore sensitive than
neural cells (Stockmann-Juvala et al., 2006), as it was observed in
this study. A possible bias for this comparison is the cell cycle state
at which cells were at the time of treatment. In this study, cells were
seeded to reach confluence at exposure in agreement with pre-
viously published work (Kroll et al., 2011, 2012). However, cells in
diverse states of the cell cycle express different biomolecules
and respond differently to exogenous stimuli (Bregoli et al., 2013).Copyright & 2015 Johnwileyonlinelibrary.com/journal/jatConclusion
ION are undoubtedly promising nanomaterials with different and
important applications in the biomedical field. As new nanoparti-
cles are currently produced and introduced to the market, it is of
paramount importance to evaluate their potential neurotoxicity,
as the self-regenerative ability of neurons is limited.
In vitro systems used herein were limited to single cell types and
therefore were not able to replicate the intricate interactions that
occur in vivo. Nevertheless, information obtained in in vitro studies
can be useful to predict new targets to define better strategies for
in vivo evaluations (de Jesus and Kapila, 2014).
Results obtained in this work show the importance of studying
nanoparticle interference in currently used cytotoxicity assays, to
obtain reliable results to improve knowledge on biological effects
of ION. Despite these possible interferences, classical cytotoxicity
assays remain standard procedure to screen nanoparticle biologi-
cal effects. Cytotoxicity screening assays presented herein allowed
the identification of adverse cellular effects on the neuroblastoma
and glioblastoma cell lines in certain conditions and, consequently,
further studies to explore protein corona formation and the under-
lying molecular mechanisms of toxicity are now matter of
investigation.
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